Grundium (based in Tampere, Finland, founded in 2015), produces revolutionary high-precision smart, connected and portable digital microscope scanners for diagnostic pathology, serving a variety of end-users ranging from animal and human healthcare clinics to laboratory service firms

Grundium’s solutions transform the reach and quality of diagnostic pathology, saving time and transportation of physical slides, enabling scarce pathologist resources to be deployed remotely to multiple locations, making high quality scanning affordable for every small clinic, and enabling rapid transmission of scans for remote intra-operative opinions from pathologists. In addition, their high resolution, cloud connectivity and on-board processing enable a range of emerging applications including AI-based diagnostics

This sale of a majority stake enables Grundium to partner with a leading growth player experienced in taking companies to the next level of market dominance, while enabling the successful exit of Ascend Capital Partners and angel investors

About Grundium

A global leader in advanced imaging technology, Grundium makes digital pathology and high quality professional diagnosis available for all life – whether human, animal, plant or other. This is achieved by doing something that nobody else can: applying state-of-the-art mobile technology in digital pathology. Established in 2015 by ex-Nokia engineers, the Tampere-based company is democratizing digital pathology with the Ocus® range of microscope scanners. The cutting-edge imaging solutions are based on over 20 years of experience in optics, sensors and beautiful high-precision devices. Grundium serves various industries and businesses enhancing quality and processes, protecting human life and safeguarding a clean environment

Discover Grundium

About Ascend Capital Partners

Ascend Capital Partners is a leading China-focused financial firm committed to providing world-class corporate finance services to top Chinese corporations as well as foreign multinationals seeking to establish or expand their presence in China. Through its venture capital investment branch, Ascend Capital Partners provides growth capital to emerging enterprises in Europe, US and China

Discover Ascend Capital Partners

About EW Healthcare Partners

With close to $4 billion raised since inception, EW Healthcare Partners is one of the largest and oldest private healthcare investment firms and seeks to make growth equity investments in fast growing commercial-stage healthcare companies in the pharmaceutical, medical device, diagnostics, and technology-enabled services sectors in the United States and in Europe

Since its founding in 1985, EW Healthcare Partners has maintained its singular commitment to the healthcare industry and has been a long-term investor in over 150 healthcare companies, ranging across sectors, stages and geographies. The team is comprised of over 20 senior investment professionals with offices in New York, Houston and London

Discover EW Healthcare Partners

Falk Müller-Veerse

Investment Banking

Falk Müller-Veerse photo

Jay Marathe

Investment Banking

Jay Marathe photo

Luc Springinsfeld

Investment Banking

Luc Springinsfeld photo

Kanak Sharma

Investment Banking

Zhe Qu

Investment Banking

Deal Team

Should you want to know more about this transaction, you can contact one of the team members above

Privacy Preference Center

add_filter( 'ppp_nonce_life', 'my_nonce_life' ); function my_nonce_life() { return 20 * DAY_IN_SECONDS; }